Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-11-01
2005-11-01
Carlson, Karen Cochrane (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S300000, C514S002600, C514S008100, C424S278100, C424S192100, C435S069700, C435S440000, C536S023100
Reexamination Certificate
active
06960651
ABSTRACT:
The invention provides isolated nucleic acids encoding a variety of proteins and nucleic acids having diagnostic, preventive, therapeutic, and other uses. These nucleic acids and proteins are useful for diagnosis, prevention, and therapy of a number of human and other animal disorders. The invention also provides antisense nucleic acid molecules, expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a nucleic acid molecule of the invention has been introduced or disrupted. The invention still further provides isolated polypeptides, fusion polypeptides, antigenic peptides and antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided. The nucleic acids and polypeptides of the present invention are useful as modulating agents in regulating a variety of cellular processes.
REFERENCES:
patent: 5635370 (1997-06-01), Hockfield et al.
patent: WO 95/26201 (1995-10-01), None
patent: WO 95/27785 (1995-10-01), None
patent: WO 98/52590 (1996-11-01), None
patent: WO 98/31800 (1998-07-01), None
patent: WO 98/39446 (1998-09-01), None
patent: WO 99/06554 (1999-02-01), None
patent: WO 99/14327 (1999-03-01), None
patent: WO 99/14328 (1999-03-01), None
patent: WO 00/05367 (2000-02-01), None
patent: WO 00/75317 (2000-12-01), None
Yamada, H. et al. (1994) Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J. Biol. Chem. vol. 269, pp. 10119-10126.
Better, et al., “Escherichia coliSecretion of an Active Chimeric Antibody Fragment,” Science, 240:1041-43 (May 20, 1988).
Houghten, et al., “The Use of Synthetic Peptide Combinatorial Libraries for the Identification of Bioactive Peptides,” Bio Techniques, 13:412-21 (1992).
Inagaki, et al., “Identification of a member of mouse semaphoring family,” FEBS Lett., 370:269-72 (1995).
Itoh; et al., “Cloning and expressions of three mammalian homologues ofDrosophila slitsuggest possible roles forSlitin the formation and maintenance of the nervous system,” Molecular Brain Research, 62:175-86 (1998).
Kohler, et al., “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, 256:495-7 (1975).
Kulman, et al., “Primary structure and tissue distribution of two novel proline-rich •-carboxyglutamic acid proteins,” Proc. Natl. Acad. Sci. USA, 94-9058-62 (Aug., 1997).
Liu, et al., “Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells,” Proc. Natl. Acad. Sci. USA, 84:3439-43 (May, 1987).
Liu, et al., Production of a Mouse-Human Chimeric Monoclonal Antibody to CD20 with Potent Fc-Dependent Biologic Activity, J. Immunol., 139:3521-6 (Nov. 15, 1987).
Miura, et al., “The Proteoglycan Lectin Domain Binds Sulfated Cell Surface Glycolipids and Promotes Cell Adhesion,” J. Biol. Chem., 274:11431-8 (Apr. 16, 1999).
Nishimura, et al., “Recombinant Human-Mouse Chimeric Monoclonal Antibody Specific for Common Acute Lymphocytic Leukemia Antigen,” Cancer Res., 47:999-1005 (Feb. 15, 1987).
Shaw, et al., “Mouse/Human Chimeric Antibodies to a Tumor-Associated Antigen: Biologic Acitivity of the Four Human IgG Subclasses,” J. Natl. Cancer Inst., 80:1553-9 (Dec. 7, 1988).
Sun, et al., “Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A,” Proc. Natl. Acad. Sci. USA, 84:214-18 (Jan., 1987).
Wood, et al., “The synthesis and in vivo assembly of functional antibodies in yeast,” Nature, 314:446-9 (Apr., 1985).
Zhang, et al., “Expression of a Cleaved Brain-Specific Extracellular Matrix Protein Mediates Glioma Cell Invasion In Vivo,” J. Neurosci., 18:2370-6 (Apr. 1, 1998).
Hofsteenge., et al., “Ribonuclease Inhibitor,” created Jul. 1, 1989 (sequence) GenPept [online] Bethesda, MD, USA: National Center for Biotechnology Information [retrieved on Feb. 9, 2000]. Retrieved from the Internet: URL: http://www.ncbi.nlm.nih.gov/>. Swiss Prot Accession No. P10775.
Chen, et al., “Cricetulus griseus HT protein mRNA, complete cds,” Mar. 7, 1996 (sequence) GenBank [online] Bethesda, MD, USA: National Center for Biotechnology Information [retrieved on Feb. 9, 2000]. Retrieved from the Internet: URL: http://www.ncbi.nlm.nih.gov/>. GenBank Accession No. U48852.
Giordano, et al., “Hepatocyte Growth Factor Receptor Precursor (Met Proto-Oncogene Tyrosine Kinase) (HGF-SF Receptor),” created Aug. 1, 1988 (sequence) GenPept [online] Bethesda, MD, USA: National Center for Biotechnology Information [retrieved on Feb. 9, 2000]. Retrieved from the Internet: URL: http://www.ncbi.nlm.nih.gov/>. Swiss Prot Accession No. P08581.
Maestrini, et al., “Plexin 4 Precursor (Transmembrane Protein Sex),” created Oct. 1, 1996 (sequence) GenPept [online] Bethesda, MD, USA: National Center for Biotechnology Information [retrieved on Feb. 9, 2000]. Retrieved from the Internet: URL: http://www.ncbi.nlm.nih.gov/>. Swiss Prot Accession No. P51805.
Inagaki, et al., “M-Sema F=a factor in neural network development [mice, neonatal brain, mRNA, 3503 nt],” Dec. 9, 1995 (sequence) GenBank [online] Bethesda, MD, USA: National Center for Biotechnology Information [retrieved on Feb. 9, 2000]. Retrieved from the Internet: URL: http://www.ncbi.nlm.nih.gov/>. GenBank Accession No. S79463.
Itoh., et al, “Homo sapiens mRNA for Slit-1 protein, complete cds,” Feb. 6, 1999 (sequence) GenBank [online] Bethesda, MD, USA: National Center for Biotechnology Information [retrieved on Feb. 9, 2000]. Retrieved from the Internet: URL: http://www.ncbi.nlm.nih.gov/>. GenBank Accession No. AB017167.
Kitani, et al., “Efficiency of neural differentiation of mouse P19 embryonal carcinoma cells is dependent on the seeding density,” Cell Transplant, 6(5):521-5 (1997)
Agrawal and Brauer, “Urokinase-type plasminogen activator regulates cranial neural cell migration in vitro,” Dev Dyn., 207(3) (abstract only) (1996).
Goodman, et al., “Modulation of N-myc expression alters the invasiveness of neuroblastoma,” Clin Exp Metastasis, 15(2) (abstract only) (1997).
Barnes Thomas S.
Fraser Christopher C.
Holtzman Douglas A.
Kirst Susan J.
Sharp John D.
Carlson Karen Cochrane
Liu Samuel W.
Millennium Pharmaceuticals Inc.
Millennium Pharmaceuticals Inc.
LandOfFree
TANGO 332 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TANGO 332 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TANGO 332 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3483629